Previous research has linked elevated CBX3 expression to poor outcomes in lung, gastric, and ovarian malignancies [27–29]; however, a study has also shown that CBX3 expression can have a tumor-suppressive effect in malignant glioma [30]. The gene discussed is CBX3; the disease is neoplasm.